Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry
Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry
Primary results from the MABLE phase IIIb study
Results of subgroup analysis of the HELIOS trial
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors
Will chemotherapy remain the cornerstone of CLL management?
Phase II study of idelalisib monotherapy in older CLL patients
History of the B-cell in its 50th anniversary year
Translational research and the future of CLL treatment
Mapping the relationship between genetics and the impact of aspirin on colorectal cancer
Why doesn’t aspirin protect everyone from colorectal cancer?
Conference overview: Aspirin in the 21st Century
Aspirin for cancer treatment and prevention